174
Participants
Start Date
August 10, 2020
Primary Completion Date
October 3, 2022
Study Completion Date
June 13, 2025
PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Will be administered as per the schedule described in individual arm.
Intravitreal Ranibizumab 0.5 mg Injection
Will be administered as per the schedule described in individual arm.
Emanuelli Research & Development Center, Arecibo
New York University (NYU), New York
Retina Vitreous Surgeons of Central New York, Liverpool
Mid Atlantic Retina;Retina Research, Philadelphia
The Retina Care Center, Baltimore
Johns Hopkins Hospital;Johns Hopkins Med;Wilmer Eye Inst, Baltimore
Cumberland Valley Retina Consultants;Clinical Research, Hagerstown
Retina Institute of Virginia, Richmond
Wagner Kapoor Institute;Opthalmology, Norfolk
Piedmont Eye Center, Lynchburg
Duke Eye Center, Durham
Charlotte Eye Ear Nose and Throat Associates- SouthPark;Retina, Charlotte
Cape Fear Retinal Associates, Wilmington
Asheville Eye Associates Western Carolina Retinal Associates;Clinical Research, Asheville
Palmetto Retina Center, West Columbia
Charleston Neuroscience, Ladson
Georgia Retina, Marietta
Southeast Retina Center, Augusta
Retina Specialty Institute, Pensacola
Fort Lauderdale Eye Institute, Plantation
Retina Associates of Florida;Retina Associates of Florida, Tampa
Tennessee Retina, Nashville
Southeastern Retina Associates, Knoxville
Charles Retina Institution;Retina surgery, Germantown
Ohio State Havener Eye Institute;Ophthalmology Research, Columbus
Associated Retinal Consultants - Royal Oak, Royal Oak
VitreoRetinal Surgery PLLC;DBA Retina Consultants of Minnesota, Minneapolis
Illinois Retina Associates, Joliet
University Retina, Lemont
Northwestern Memorial Hospital, Chicago
Pepose Vision Institute, Chesterfield
Retina Associates, Lenexa
Retina Vitreous Center - Glen Eagles, Edmond
Texas Retina Associates;Research, Dallas
Retina Center of Texas, Grapevine
Retina & Vitreous of Texas, Bellaire
Retina Consultants of Texas, Houston
Medical Center Ophthalmology Associates, San Antonio
Austin Retina Associates;Opthalmology, Austin
Retina Research Institute of Texas, Abilene
Colorado Clinical Research, Lakewood
Southwest Retina Research Center, Durango
Rocky Mountain Retina Consultants, Murray
Retina Associates of Utah, PLLC;Clinical Research, Salt Lake City
Retinal Consultants of Arizona;Opthalmology, Phoenix
Associated Retina Consultants, Phoenix
Barnet Dulaney Perkins Eye Center, Mesa
Sierra Eye Associates, Reno
Jules Stein Eye Institute/ UCLA, Los Angeles
California Eye Specialists Medical Group, Pasadena
The Retina Partners, Encino
Kaiser Permanente;RESEARCH AND EVALUATION, Riverside
Orange County Retina Medical Group, Santa Ana
Retina Consultants of Orange County;Clinical Research, Fullerton
California Retina Consultants, Bakersfield
Retina Consultants Medical Group, Sacramento
Retina Consultants of Hawaii at Pali Momi Medical Center, ‘Aiea
Retina Northwest;Research Department, Portland
Pacific Northwest Retina, Silverdale
Spokane Eye Clinical Research;Spokane Eye Surgery Center, Spokane
Retina Group of New England, Waterford
Maine Eye Center, Portland
Envision Ocular, LLC, Bloomfield
Retina Associates of New Jersey, Teaneck
Hoffmann-La Roche
INDUSTRY